| Producing polished prokaryotic pangenomes with the Panaroo pipeline G Tonkin-Hill, N MacAlasdair, C Ruis, A Weimann, G Horesh, JA Lees, ... Genome biology 21, 1-21, 2020 | 521 | 2020 |
| Bioanalytical advances in assays for C-reactive protein SK Vashist, AG Venkatesh, EM Schneider, C Beaudoin, PB Luppa, ... Biotechnology advances 34 (3), 272-290, 2016 | 140 | 2016 |
| Clinically relevant analytical techniques, organizational concepts for application and future perspectives of point-of-care testing PB Luppa, A Bietenbeck, C Beaudoin, A Giannetti Biotechnology Advances 34 (3), 139-160, 2016 | 90 | 2016 |
| SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets AF Alsulami, SE Thomas, AR Jamasb, CA Beaudoin, I Moghul, ... Briefings in bioinformatics 22 (2), 769-780, 2021 | 35 | 2021 |
| Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses CA Beaudoin, AR Jamasb, AF Alsulami, L Copoiu, AJ van Tonder, S Hala, ... Computational and Structural Biotechnology Journal 19, 3938-3953, 2021 | 35 | 2021 |
| Unheeded SARS-CoV-2 proteins? A deep look into negative-sense RNA M Bartas, A Volná, CA Beaudoin, ET Poulsen, J Červeň, V Brázda, ... Briefings in bioinformatics 23 (3), bbac045, 2022 | 28 | 2022 |
| Can the SARS-CoV-2 spike protein bind integrins independent of the RGD sequence? CA Beaudoin, SW Hamaia, CLH Huang, TL Blundell, AP Jackson Frontiers in Cellular and Infection Microbiology 11, 765300, 2021 | 18 | 2021 |
| In silico analysis of mutations near S1/S2 cleavage site in SARS‐CoV‐2 spike protein reveals increased propensity of glycosylation in Omicron strain CA Beaudoin, AP Pandurangan, SY Kim, SW Hamaia, CLH Huang, ... Journal of Medical Virology 94 (9), 4181-4192, 2022 | 15 | 2022 |
| Searching for new Z-DNA/Z-RNA binding proteins based on structural similarity to experimentally validated Zα domain M Bartas, K Slychko, V Brázda, J Červeň, CA Beaudoin, TL Blundell, ... International Journal of Molecular Sciences 23 (2), 768, 2022 | 15 | 2022 |
| Are there hidden genes in DNA/RNA vaccines? CA Beaudoin, M Bartas, A Volná, P Pečinka, TL Blundell Frontiers in immunology 13, 801915, 2022 | 12 | 2022 |
| Magnetic bead fluorescent immunoassay for the rapid detection of the novel inflammation marker YKL40 at the point-of-care M Schmalenberg, C Beaudoin, L Bulst, D Steubl, PB Luppa Journal of Immunological Methods 427, 36-41, 2015 | 10 | 2015 |
| SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate CA Beaudoin, E Petsolari, SW Hamaia, S Hala, FS Alofi, AP Pandurangan, ... Biochemical and Biophysical Research Communications 666, 61-67, 2023 | 2 | 2023 |
| Evolution of targets at the host-pathogen interface C Beaudoin | | 2024 |
| Isoform-specific N-linked glycosylation of voltage-gated sodium channel alpha-subunits alters beta-subunit binding sites CA Beaudoin, M Kohli, SC Salvage, H Liu, SJ Arundel, SW Hamaia, M Lei, ... bioRxiv, 2024.05. 20.594950, 2024 | | 2024 |
| Similarity of drug targets to human microbiome metaproteome promotes pharmacological promiscuity CA Beaudoin, S Norget, S Hala, AJ van Tonder bioRxiv, 2024.04. 26.591258, 2024 | | 2024 |
| Modelling and Molecular Dynamics Predict the Structure and Interactions of the Glycine Receptor Intracellular Domain JRE Thompson, CA Beaudoin, SCR Lummis Biomolecules 13 (12), 1757, 2023 | | 2023 |
| Antigenic Structural Similarity as a Predictor for Antibody Cross-Reactivity C Beaudoin, T Blundell Journal of Bacteriology & Parasitology, 2021 | | 2021 |
| Genetic Characterization of the Gut Microbiome of Hajj Pilgrims C Beaudoin | | 2018 |
| Comparison of anti-proliferation activity of BEZ 235, a multi-step inhibitor of mTOR pathway, vs. BKM120, a pan PI3K inhibitor, in lung cancer cell lines (LCCL) CH Huang, C Beaudoin, PV Veldhuizen, F Farassati Cancer Research 74 (19_Supplement), 4528-4528, 2014 | | 2014 |
| Inhibition of Mycobacterium tuberculosis RecA C Beaudoin, T O’Brien, T Blundell | | |
